- ESHAP Salvage Therapy for Refractory and Relapsed Non-Hodgkins Lymphoma: A Single Center Experience
-
Park SH, Kim S, Ko OB, Koo JE, Lee D, Jeong YP, Huh J, Kim SB, Kim SW, Lee JL, Suh C
- KMID: 759841
- Korean J Intern Med.
- 2006 Sep;21(3):159-164.
- doi: 10.3904/kjim.2006.21.3.159
BACKGROUND: The ESHAP chemotherapy regimen, that is, the combination of the etoposide, methylprednisolone, high-dose cytarabine and cisplatin, has been shown to be active against relapsing or refractory non-Hodgkin's lymphoma... -
- CITED
-
- Close
- SHARE
-
- Close
